Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0011570 (
depression
)
172,036
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
It has been proposed that signaling pathways involved in adaptive neural plasticity are long-term targets for the action of electroconvulsive treatment (ECT), which is widely used in the treatment of drug-resistant
depression
. We have previously performed EST analysis to identify some molecular machinery responsible for antidepressant effect. One of the cDNA fragments identified as antidepressant related genes/ESTs was identified as
kf-1
which has a RING-H2 finger motif at the carboxy-terminus. In the present study, we have demonstrated the induction of
kf-1
in rat frontal cortex and hippocampus not only after chronic antidepressant treatment, but also after a single and repeated ECT. RING finger proteins are proposed to play some important roles in the ubiquitin-proteasome system. In conclusion, the current investigation has identified
kf-1
as a novel molecular target for antidepressants and ECT.
...
PMID:Induction of kf-1 after repeated electroconvulsive treatment and chronic antidepressant treatment in rat frontal cortex and hippocampus. 1265 76
Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive approach used for stimulating the brain, and has proven effective in the treatment of
depression
, however the mechanism of its antidepressant action is unknown. Recently, we have reported the induction of
kf-1
in rat frontal cortex and hippocampus after chronic antidepressant treatment and repeated electroconvulsive treatment (ECT). In this study, we demonstrated the induction of
kf-1
after rTMS in the rat frontal cortex and hippocampus, but not in hypothalamus. Our data suggest that
kf-1
may be a common functional molecule that is increased after antidepressant treatment, ECT and rTMS. In conclusion, it is proposed that induction of
kf-1
may be associated with the treatment induced adaptive neural plasticity in the brain, which is a long-term target for their antidepressant action.
...
PMID:Repetitive transcranial magnetic stimulation induces kf-1 expression in the rat brain. 1576 74
KF-1
was originally identified as a protein encoded by human gene with increased expression in the cerebral cortex of a patient with Alzheimer's disease. In mouse brain,
kf-1
mRNA is detected predominantly in the hippocampus and cerebellum, and
kf-1
gene expression is elevated also in the frontal cortex of rats after chronic antidepressant treatments.
KF-1
mediates E2-dependent ubiquitination and may modulate cellular protein levels as an E3 ubiquitin ligase, though its target proteins are not yet identified. To elucidate the role of
kf-1
in the central nervous system, we generated
kf-1
knockout mice by gene targeting, using Cre-lox recombination. The resulting
kf-1
(-/-) mice were normal and healthy in appearance. Behavioral analyses revealed that
kf-1
(-/-) mice showed significantly increased anxiety-like behavior compared with
kf-1
(+/+) littermates in the light/dark transition and elevated plus maze tests; however, no significant differences were observed in exploratory locomotion using the open field test or in behavioral despair using the forced swim and tail suspension tests. These observations suggest that
KF-1
suppresses selectively anxiety under physiological conditions probably through modulating protein levels of its unknown target(s). Interestingly,
kf-1
(-/-) mice exhibited significantly increased prepulse inhibition, which is usually reduced in human schizophrenic patients. Thus, the
kf-1
(-/-) mice provide a novel animal model for elucidating molecular mechanisms of psychiatric diseases such as anxiety/
depression
, and may be useful for screening novel anxiolytic/antidepressant compounds.
...
PMID:Mice lacking the kf-1 gene exhibit increased anxiety- but not despair-like behavior. 1895 94
Anxiety is an instinct that may have developed to promote adaptive survival by evading unnecessary danger. However, excessive anxiety is disruptive and can be a basic disorder of other psychiatric diseases such as
depression
. The
KF-1
, a ubiquitin ligase located on the endoplasmic reticulum (ER), may prevent excessive anxiety;
kf-1
(-/-) mice exhibit selectively elevated anxiety-like behavior against light or heights. It is surmised that
KF-1
degrades some target proteins, responsible for promoting anxiety, through the ER-associated degradation pathway, similar to Parkin in Parkinson's disease (PD). Parkin, another ER-ubiquitin ligase, prevents the degeneration of dopaminergic neurons by degrading the target proteins responsible for PD. Molecular phylogenetic studies have revealed that the prototype of
kf-1
appeared in the very early phase of animal evolution but was lost, unlike parkin, in the lineage leading up to Drosophila. Therefore,
kf-1
(-/-) mice may be a powerful tool for elucidating the molecular mechanisms involved in emotional regulation, and for screening novel anxiolytic/antidepressant compounds.
...
PMID:KF-1 Ubiquitin Ligase: An Anxiety Suppressor. 1975 93